Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kontoyiannis, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kontoyiannis, D. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 46, 191-197
© 2000 The British Society for Antimicrobial Chemotherapy

Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae

Dimitrios P. Kontoyiannis*

The University of Texas M. D. Anderson Cancer Center, Section of Infectious Diseases, 1515 Holcombe Boulevard, Box 47, Houston, TX 77030, USA

We studied the effects of fluconazole, an ergosterol-depleting agent, in Saccharomyces cerevisiae, a genetically tractable fungus closely related to Candida albicans. The wild-type Saccharomyces strain was sensitive to fluconazole, but the isogenic cytoplasmic petite mutant (rho–) was resistant. The mechanism of resistance of rho– mutants appeared to involve uncoupling of oxidative phosphorylation. However, the petite strain with a mutation in ¢5,6 desaturase (erg3 rho–) was sensitive to fluconazole, in contrast to its erg3 rho+ counterpart. It is known that erg3 mutants are azole resistant through the accumulation of 14-methyl-fecosterol, a less toxic ergosterol intermediate. These results indicate that mitochondria function as important physiological partners with Erg3p in the accumulation of toxic sterol intermediates in the presence of azoles.

* Corresponding author. Tel: +1-713-792-0826; Fax: +1-713-794-4351; E-mail: dkontoyi{at}notes.mdacc.tmc.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
P. Vandeputte, G. Tronchin, F. Rocher, G. Renier, T. Berges, D. Chabasse, and J.-P. Bouchara
Hypersusceptibility to Azole Antifungals in a Clinical Isolate of Candida glabrata with Reduced Aerobic Growth
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3034 - 3041.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
B. G. Oliver, P. M. Silver, C. Marie, S. J. Hoot, S. E. Leyde, and T. C. White
Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi
Microbiology, March 1, 2008; 154(3): 960 - 970.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. Vandeputte, G. Larcher, T. Berges, G. Renier, D. Chabasse, and J.-P. Bouchara
Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis
Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4608 - 4615.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. Kaur, I. Castano, and B. P. Cormack
Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria
Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1600 - 1613.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Brun, T. Berges, P. Poupard, C. Vauzelle-Moreau, G. Renier, D. Chabasse, and J.-P. Bouchara
Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata
Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1788 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M.-Y. S. Moosa, J. D. Sobel, H. Elhalis, W. Du, and R. A. Akins
Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium
Antimicrob. Agents Chemother., January 1, 2004; 48(1): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. Y. Young, C. M. Hull, and J. Heitman
Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae
Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2717 - 2724.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Brun, C. Aubry, O. Lima, R. Filmon, T. Berges, D. Chabasse, and J.-P. Bouchara
Relationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata
Antimicrob. Agents Chemother., March 1, 2003; 47(3): 847 - 853.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Mukhopadhyay, A. Kohli, and R. Prasad
Drug Susceptibilities of Yeast Cells Are Affected by Membrane Lipid Composition
Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3695 - 3705.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. P. Kontoyiannis and G. S. May
{{delta}}-Aminolaevulinic acid modulates the resistance to fluconazole in a hem1 mutant of Saccharomyces cerevisiae
J. Antimicrob. Chemother., December 1, 2000; 46(6): 1044 - 1046.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.